Literature DB >> 32538459

The incidence of bullous pemphigoid continues to increase in England.

C E Bax1,2, V P Werth1,2.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32538459      PMCID： PMC8292922          DOI： 10.1111/bjd.19207

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  10 in total

1.  Incidence of bullous pemphigoid and pemphigus vulgaris.

Authors:  Pascal Joly
Journal:  BMJ       Date:  2008-07-09

Review 2.  Ethnicity and Type 2 diabetes in the UK.

Authors:  L M Goff
Journal:  Diabet Med       Date:  2019-01-23       Impact factor: 4.359

3.  A comparison of oral and topical corticosteroids in patients with bullous pemphigoid.

Authors:  Pascal Joly; Jean-Claude Roujeau; Jacques Benichou; Catherine Picard; Brigitte Dreno; Emmanuel Delaporte; Loic Vaillant; Michel D'Incan; Patrice Plantin; Christophe Bedane; Paul Young; Philippe Bernard
Journal:  N Engl J Med       Date:  2002-01-31       Impact factor: 91.245

4.  Annual incidence and mortality of bullous pemphigoid in the Grampian Region of North-east Scotland.

Authors:  V S Gudi; M I White; N Cruickshank; R Herriot; S L Edwards; F Nimmo; A D Ormerod
Journal:  Br J Dermatol       Date:  2005-08       Impact factor: 9.302

5.  Dipeptidyl peptidase IV inhibitors, a risk factor for bullous pemphigoid: Retrospective multicenter case-control study from France and Switzerland.

Authors:  Michael Benzaquen; Luca Borradori; Philippe Berbis; Simone Cazzaniga; René Valero; Marie-Aleth Richard; Laurence Feldmeyer
Journal:  J Am Acad Dermatol       Date:  2017-12-21       Impact factor: 11.527

6.  The relationship between neurological disease and bullous pemphigoid: a population-based case-control study.

Authors:  Sinéad M Langan; Richard W Groves; Joe West
Journal:  J Invest Dermatol       Date:  2010-11-18       Impact factor: 8.551

7.  Incidence, prevalence and mortality of bullous pemphigoid in England 1998-2017: a population-based cohort study.

Authors:  M S M Persson; K E Harman; Y Vinogradova; S M Langan; J Hippisley-Cox; K S Thomas; S Gran
Journal:  Br J Dermatol       Date:  2020-04-27       Impact factor: 9.302

8.  Increased risk of bullous pemphigoid in dipeptidyl peptidase 4 inhibitors: A nationwide, population-based, cohort study in Taiwan.

Authors:  Chih-Tsung Hung; Jhih-Syuan Liu; Cheng-Yi Cheng; Chi-Hsiang Chung; Chien-Ping Chiang; Wu-Chien Chien; Wei-Ming Wang
Journal:  J Dermatol       Date:  2019-12-29       Impact factor: 4.005

9.  Incidence of bullous pemphigoid in Sweden 2005-2012: a nationwide population-based cohort study of 3761 patients.

Authors:  Kristofer Thorslund; Oliver Seifert; Karin Nilzén; Carina Grönhagen
Journal:  Arch Dermatol Res       Date:  2017-09-05       Impact factor: 3.017

10.  Bullous pemphigoid and pemphigus vulgaris--incidence and mortality in the UK: population based cohort study.

Authors:  S M Langan; L Smeeth; R Hubbard; K M Fleming; C J P Smith; J West
Journal:  BMJ       Date:  2008-07-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.